Honda, Masataka
Horiuchi, Hideki
Torii, Tomoko
Nakajima, Akihiro
Iijima, Takeshi
Murano, Hiroshi
Yamanaka, Hisashi
Ito, Shuichi
Article History
Received: 29 June 2021
Accepted: 30 November 2021
First Online: 18 December 2021
Declarations
:
: Not applicable.
: Not applicable.
: The first draft of this paper was written by MH and HH, with writing and editing support from EDIT, Inc. (Tokyo, Japan) and financial support from Teijin Pharma Limited. The sponsor (Teijin Pharma Limited) designed the study, collected and analyzed data, wrote the report, and decided to submit the manuscript for publication in cooperation with the academic authors.MH reports personal fees from Teijin Pharma Limited; HH, TT, AN, TI, and HM are employees of Teijin Pharma Limited; HY reports grants and personal fees from Teijin Pharma Limited; SI reports personal fees, non-financial support, and other relationships from Teijin Pharma Limited.